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Acute Effects of Cadmium on the
Pregnant Rat and Embryo-Fetal
Development
by G. P. Samarawickrama* and M. Webb*
In rats, ofthe Wistar-Porton strain, a single intravenous injection of 1.25 mg Cd1+ between days 9 and
15 of gestation results in a high incdence (80%o of hydrocephalus, togethr with other malformaton In
the fetuses, examed on day 20. This dose is cridcal, since 1.1 mg Cdc+/kg is not teragepnic, while 1.35 nig
Cd2+/kg kills all the embryos. Intravenous injection of Cd2+ to the pregnant rat on day 12 causes a
dose-dependent inhibition ofplacental Zn2+ transport. At the teratogenic dose, Zn2+ transport is inhibited
by about 75% at 4 hr. Thereafter, inhibition decreases with time but is stil significant at 48 hr. At 20 hr
after administration of CdF+ the embryonic concentration of Zn2+ is depressed by 33%. In the whole
embryo the activity ofthe Zn2+-dependent thymidine kinase is inhibited by about60%o at 4 hrand at 20hr
the DNA concentration is reduced significantly. Placental transportof'4C-leucine and '4C-uridine, as well
as the embryonic incorporation of these precursors into protein and RNA is unaffected at least at short
times after the administration ofCd2+. It is possible therefore, that the teratogenic effects ofCd2+ may be
related to the inhibition of DNA synthesis in the embryo.
Pregnancy represents a period of high suscepti-
bility to parenterally administered cadmium (Cd2+).
In rats, Parizek (1, 2) has shown that a single sub-
cutaneous injection of 40 ,umole CdCl2/kg body
weight on days 17 to 21 ofgestation, results in de-
struction of the fetal portion of the placenta with
death of the embryos in a high proportion of preg-
nant animals. In female rats of the Wistar-Porton
strain used in our laboratory which have agestation
period of 21 days, the intravenous LD50 drops sig-
nificantly from the virgin female level of 1.77 mg to
1.05 mg Cd2+/kg body weight on day 20 ofgestation
(p < 0.001; df = 30). Immediately after the admin-
istration of the LD50 dose, both gravid and non-
gravid animals develop flushed extremities, due to
vasodilatation, rapid shallow respiration, apathy
and flaccidity ofmuscles. At this dose, most deaths
occurbetween 16 and 24 hr. With higherdoses most
of the animals succumb within 6 hr, the predomi-
nant pathological lesion being subpleural hemor-
rhage of the lung. Just before death these animals
develop violent seizures. Palpation, immediately
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after the animal has stopped breathing reveals that
the heart is still beating, and this finding suggests
respiratory paralysis. Both this respiratory failure
and the initial muscular flaccidity probably are due
to neuromuscular block. Such effects ofCd2+ have
been observed by Forshaw (3) in isolated prepara-
tion of the rat hemidiaphragm and seem to result
from a competitive displacement of calcium.
Pregnant animals that die between 16 and 24 hr
after the administration of the LD50 dose of Cd2+
show vaginal bleeding at 8 hr, indicative ofplacental
damage. Histology at this stage shows degeneration
ofthe maternal partofthe placenta(Fig. 1), which is
in contrast to Parizek's findings (1, 2) that sub-
cutaneous injection of Cd2+ salts is followed in all
cases by rapidly progressive placental changes,
chiefly ofpars fetalis. The liver and the kidneys are
edematous and hyperemic. The fetuses are pale in
color and in distress, as shown by the presence of
meconium-stained liquor amnii. At 20 hr the mater-
nal animal is extremely pale, with severe hemor-
rhage per vaginum. Histology reveals that the
placenta has lost its architecture and, as observed
by Parizek (1), has turned into an extensive blood
clot (Fig. 2). The liver exhibits periacinar necrosis,
and the kidneys show vacuolation ofthe cells ofthe
proximal convoluted tubules. Many areas in the
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epithelium, and sometimes homogeneous casts that
are probably proteinaceous. There are areas with
complete degeneration of the proximal convoluted
tubules. Inflammatory cells are never in large num-
bers but are scattered in areas containing altered
tubules. The glomeruli and the distal convoluted
tubules are spared. Thus, death at this stage may be
due to a combination of retroplacental hemorrhage
and hepatorenal failure. Nongravid females do not
show these hepatic and renal changes at this dose
(1.05 mg Cd2+/kg), though the lungs show occa-
sional subpleural hemorrhage.
In addition to its increased toxicity at or near
term, Cd2+ is known to cause congenital deformities
in rats, mice, and hamsters (4-7), when adminis-
tered during a particular period ofgestation. In the
present work a single intravenous dose of 1.25 mg
Cd2+ between days 8 and 15 ofgestation was found
to be extremely teratogenic and to induce one or
more deformities in a high percentage ofthe fetuses
(Table 1). The most frequent ofthese deformities is
hydrocephalus, which is seen in 80o of the fetuses
when examined, after delivery by cesarean section
on day 20.
In addition, anophthalmia, microphthalmia, gas-
troschiasis, and umbilical hernia are present in 45%
of the fetuses. Though the incidence of hy-
drocephalus is highest when Cd2+ is given on day
10, this deformity also occurs in a great number of
fetuses when the cation is administered on day 12 of
gestation. As, at this stage ofdevelopment, the em-
bryos are of reasonable size, most of the following
biochemical work has been done with animals
treated with a dose of 1.25 mg Cd2+/kg body weight
on day 12 of gestation. This dose is critical, since
1.10 mg does not produce malformations, while 1.35
mg Cd2+/kg kills all the embryos.
After the intravenous injection of isotopically
labelled Cd2+ (1.25 mg/kg) to the pregnant rat on day
12 of gestation, extremely small amounts of Cd2+,
i.e., about 16 ng/g wet weight tissue, are detectable
in the embryos at 4 hr. At 24 hr, the amount is even
smaller-about 5 ng Cd2+/g wet weight tissue. At
these times the corresponding total placental con-
centrations of Cd2+ are 2 and 0.8 ,g/g wet weight,
FIGURE 1. Placenta from a 20-day pregnant rat 8 hr after an intravenous injection of 1.25 mg Cd2+/kg. The maternal blood vessels have
undergone degeneration and the villi (see bottom of the picture) are spared.
Environmental Health Perspectives 246b s :Ai.
lb ,Ab
FIGURE 2. Placenta from a 20-day pregnant rat 24 hr after an intravenous injection of 1.25 mg Cd2+/kg. Note the loss of placental
architecture.
Table 1. Effects of intravenous injection of 1.25 mg Cd2+/kg body weight on different days of gestation in the rat.a
Average % Dead Average No. of No. of Anomalies in all litters
Day of No. of live per or fetal abnormal abnormal
gestation litters litter resorbed weight, g litters fetuses Brain Eye Others
8 15 12 12.5 2.5 10 96 67 32 14
9 15 13 14.2 2.5 12 176 156 41 28
10 15 12 15.1 3.1 13 160 144 29 17
11 15 9 14.7 3.0 13 112 64 31 26
12 15 10 16.4 3.2 11 96 41 37 24
13 15 10 14.1 3.0 12 64 9 16 48
14 15 8 20.0 3.1 12 52 67
15 15 7 26.2 2.9 11 24 - - 34
a The maternal animals killed and examined on the 20th day of gestation.
respectively; i.e., 100-150 times greater than the
embryonic levels. This loss ofCd2+ from the 12-day
embryo may be due at least in part to the absence of
the high affinity Cd2+-binding protein, thionein,
since the development of the liver and kidneys is
justbeginning at this time. Neither zinc-thionein nor
cadmium-thionein is present in the 12-day embryos
from normal and Cd2+-treated dams, respectively.
In contrast, at 20 days the liver and kidneys of the
normal fetus are well developed and the hepatic
concentration of zinc-thionein is extremely high.
When Cd2+ is administered to the mother at this
stage ofgestation, uptake ofthe cation by the fetus
is greater at 24 hr than at 4 hr and, under these
conditions, most of the cadmium that reaches the
fetus is accumulated in the liver, specifically in the
metallothionein fraction.
In agreement with these analytical mea-
surements, 109Cd2+ can be detected by autoradiog-
raphy in the livers offetuses from pregnant animals
February 1979 247that are dosed with the labeled cation on day 20 of
gestation, but not in the whole embryos of females
that are treated in the same way on day 12.
Although little Cd2+ reaches the embryo on day
12 ofgestation, its presence inthe placenta seems to
interfere with the function ofthis organ, particularly
with the transport of Zn2+; a cation for which the
embryo has a high demand at this stage ofdevelop-
ment (8, 9). Thus at 4 hr after a dose of 0.5 mg
Cd2+/kg, transport of 65Zn+ across the placenta is
inhibited by nearly 50%, and at 1.25 mg/kg it is re-
duced to about 25% ofthe control values (Table 2).
Even after a dose of Cd2+ as low as 0.25 mg/kg
inhibition is appreciable, although not statistically
significant. At 1.25 mg the inhibition persists and
remains significant at 48 hr.
Quantitative interpretation ofthese results is dif-
ficult because ofthe changes caused by Cd2+ in the
concentrations ofZn2+ inthe plasmaandotherbody
compartments of the maternal animal. Neverthe-
less, as intravenous administration of Cd2+ results
in an initial dose dependent depression of blood
Zn2+, the effects of Cd2+ on total Zn2+ transport
across the placenta are likely to be greater, notless,
than those revealed by the measurements of65Zn2+
uptake. As a result of the inhibition of Zn2+ trans-
port, the Zn2+ concentration of the embryo is re-
duced by 33% at 20 hr after the intravenous injec-
Table 2. Effect ofcadmium onembryonic uptake of 5Zn on day 12
ofgestation in the rat.
dose blMoodeZnl Embryonic 65Zn uptakea
mg/kg ,uglg itg/g % ofcontrol
0 7.4 4.9 100.0
0.25 6.2 3.9 80.0
0.50 - 2.6 53.1
0.75 - 2.2 44.9
1.00 1.7 34.7
1.25 5.6 1.3 26.5
a Uptake measured at 15 min after the I.V. administration of
"ZnCI2 (3 ,uCi) to the maternal animal.
tion of 1.25 mg Cd2+/kg body weight to the maternal
animal.
Maternal Zn2+ deficiency is known to lead to
teratogenic effects in the rat (8, 10) and to reduce
thymidine incorporation (11), particularly in the de-
veloping brain of the 12-day embryo. Such effects
have been attributed to the inhibition of the Zn2+-
dependent enzyme, thymidine kinase. When Cd2+
(1.25 mg/kg body weight) is administered to 12-day
pregnant rats, followed at 4, 20, and 48 hr by a
15-min pulse of14C thymidine (3 ,uCi), the transport
of the latter at any time is found to be unaffected.
Incorporation of thymidine into the embryonic
DNA, however, is inhibited significantly at 4 and 20
hr although at 48 hr it is similar to that in the con-
trols (Table 3). The total DNA content of the em-
bryo is little affected at 4 hr but at 20 and 48 hr it is
reduced significantly.
Since Cd2+ blocks both thymidine incorporation
into embryonic DNA and also the placental transfer
of Zn2+, the former may be a direct result of the
latter. Thymidine incorporation into embryonic
DNA, however, is inhibited as early as 4 hrafterthe
administration of Cd2+ to the maternal animal, that
is before any measurable change has occurred in
embryonic Zn2+ concentration. Furthermore, the
effect of Cd2+ on placental Zn2+ transport is still
apparent at 48 hr, whereas DNA synthesis has re-
turned to the control level atthis time. It is possible,
therefore, that the small amounts of Cd2+ that are
incorporated into the 12-day embryo have a direct
inhibitory action on thymidine kinase. In vitro, this
enzyme is known to be inhibited by Cd2+ (12). Inhi-
bition ofembryonic DNA synthesis, therefore, may
be related to the teratogenic effects of Cd2+, par-
ticularly as the uptake and incorporation of 14C_
uridine and 14C-leucine by the embryos are not af-
fected at 4 hrafterthe administration ofCd2+. Thus,
at a time when DNA synthesis is inhibited appreci-
ably, RNA and protein production are unaffected.
G. P. Samarawickrama is a W.H.O. fellow, Sri Lanka.
Table 3. Changes in thymidine incorporation and DNA concentration in the rat embryo following the administration of Cd,+ to the
maternal animal.
'4C-Thymidine
incorporation into DNA concentration,
Time after embryonic DNA, ,ug/mg
administration counts/min/mg DNAb wet weight tissueb
ofCd2+, Cd+ Cd2+
hP treated Control treated Control
4 4800 12850 4.33 4.42
20 1400 5900 3.42 4.20
48 4800 5200 3.52 4.35
a Rats were dosed with Cd2+ (1.25 mg/kg) on day 12 ofpregnancy.
" Each value is the mean ofthree determinations.
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